HU165790B - - Google Patents

Info

Publication number
HU165790B
HU165790B HUCE872A HUCE000872A HU165790B HU 165790 B HU165790 B HU 165790B HU CE872 A HUCE872 A HU CE872A HU CE000872 A HUCE000872 A HU CE000872A HU 165790 B HU165790 B HU 165790B
Authority
HU
Hungary
Application number
HUCE872A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU165790B publication Critical patent/HU165790B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HUCE872A 1971-04-09 1972-04-07 HU165790B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7104839.A NL167151C (nl) 1971-04-09 1971-04-09 Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.

Publications (1)

Publication Number Publication Date
HU165790B true HU165790B (cg-RX-API-DMAC7.html) 1974-11-28

Family

ID=19812895

Family Applications (1)

Application Number Title Priority Date Filing Date
HUCE872A HU165790B (cg-RX-API-DMAC7.html) 1971-04-09 1972-04-07

Country Status (19)

Country Link
US (1) US3884906A (cg-RX-API-DMAC7.html)
JP (2) JPS5525177B1 (cg-RX-API-DMAC7.html)
AR (2) AR194587A1 (cg-RX-API-DMAC7.html)
AU (1) AU459272B2 (cg-RX-API-DMAC7.html)
BE (1) BE781674A (cg-RX-API-DMAC7.html)
CH (2) CH586182A5 (cg-RX-API-DMAC7.html)
DE (1) DE2215409C3 (cg-RX-API-DMAC7.html)
DK (1) DK143227C (cg-RX-API-DMAC7.html)
ES (1) ES401501A1 (cg-RX-API-DMAC7.html)
FR (1) FR2132788B1 (cg-RX-API-DMAC7.html)
GB (1) GB1346266A (cg-RX-API-DMAC7.html)
HU (1) HU165790B (cg-RX-API-DMAC7.html)
IE (1) IE36209B1 (cg-RX-API-DMAC7.html)
IL (1) IL39108A (cg-RX-API-DMAC7.html)
NL (1) NL167151C (cg-RX-API-DMAC7.html)
PH (2) PH15268A (cg-RX-API-DMAC7.html)
SE (1) SE389331B (cg-RX-API-DMAC7.html)
SU (1) SU580828A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA722331B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4101678A (en) * 1977-11-08 1980-05-01 Ici Australia Ltd Process for killing parasites
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
EA011158B1 (ru) * 2004-03-16 2009-02-27 Бёрингер Ингельхайм Интернациональ Гмбх Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20090938A1 (es) * 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
US8648085B2 (en) * 2007-11-30 2014-02-11 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
CN102143965A (zh) 2008-09-08 2011-08-03 贝林格尔.英格海姆国际有限公司 吡唑并嘧啶酮及其在治疗中枢神经系统疾病中的用途
US20110014284A1 (en) * 2009-02-13 2011-01-20 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
KR20110118668A (ko) 2009-02-13 2011-10-31 베링거 인겔하임 인터내셔날 게엠베하 1형 당뇨병, 2형 당뇨병, 내당능 장애 또는 고혈당증을 치료하기 위한 sglt­2 억제제
MX339194B (es) 2009-02-13 2016-05-16 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de sglt2, un inhibidor de dpp-iv y opcionalmente otro agente antidiabetico, y usos de la misma.
UY32531A (es) 2009-03-31 2010-10-29 Boehringer Ingelheim Int Nuevos compuestos para el tratamiento de trastornos del snc
AR077859A1 (es) * 2009-08-12 2011-09-28 Boehringer Ingelheim Int Compuestos para el tratamiento de trastornos del snc
DK2486029T3 (en) 2009-09-30 2015-08-24 Boehringer Ingelheim Int Methods of making of glucopyranosyl-substituted benzyl-benzene derivatives.
ES2596202T3 (es) * 2009-09-30 2017-01-05 Boehringer Ingelheim International Gmbh Método para la preparación de una forma cristalina de 1-cloro-4-(ß-D-glucopiranos-1-il)-2-[4-((S)-tetrahidrofuran-3-iloxi)-bencil]-benceno
US10610489B2 (en) * 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
BR112013003097B1 (pt) 2010-08-12 2021-03-16 Boehringer Ingelheim International Gmbh 6-cicloalquil-pirazolopirimidinonas e composição farmacêutica
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HRP20190101T1 (hr) 2013-04-05 2019-03-08 Boehringer Ingelheim International Gmbh Terapeutske uporabe empagliflozina
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
PL2986304T3 (pl) 2013-04-18 2022-05-02 Boehringer Ingelheim International Gmbh Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
WO2018087132A1 (en) 2016-11-10 2018-05-17 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544826A (en) * 1945-05-08 1951-03-13 Dow Chemical Co Anthelmintic feed composition
US2615052A (en) * 1950-06-23 1952-10-21 Allied Lab Inc 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production
US2739941A (en) * 1952-09-13 1956-03-27 Gen Aniline & Film Corp Germicidal soap composition
NL283922A (cg-RX-API-DMAC7.html) * 1962-10-03

Also Published As

Publication number Publication date
GB1346266A (en) 1974-02-06
FR2132788B1 (cg-RX-API-DMAC7.html) 1976-05-14
NL7104839A (cg-RX-API-DMAC7.html) 1972-10-11
IE36209B1 (en) 1976-09-15
PH15268A (en) 1982-11-02
DE2215409A1 (de) 1973-01-25
AR194587A1 (es) 1973-07-31
US3884906A (en) 1975-05-20
PH14191A (en) 1981-03-26
DK143227C (da) 1981-11-30
DE2215409B2 (de) 1980-02-14
BE781674A (fr) 1972-10-05
JPS5950645B2 (ja) 1984-12-10
JPS557256A (en) 1980-01-19
SE389331B (sv) 1976-11-01
IL39108A (en) 1976-04-30
DK143227B (da) 1981-07-27
AU459272B2 (en) 1975-03-05
DE2215409C3 (de) 1980-10-09
AU4085072A (en) 1973-10-11
NL167151C (nl) 1981-11-16
IE36209L (en) 1972-10-09
ZA722331B (en) 1973-01-31
JPS5525177B1 (cg-RX-API-DMAC7.html) 1980-07-04
ES401501A1 (es) 1975-02-16
CH575372A5 (cg-RX-API-DMAC7.html) 1976-05-14
NL167151B (nl) 1981-06-16
CH586182A5 (cg-RX-API-DMAC7.html) 1977-03-31
IL39108A0 (en) 1972-05-30
FR2132788A1 (cg-RX-API-DMAC7.html) 1972-11-24
AR193590A1 (es) 1973-04-30
SU580828A3 (ru) 1977-11-15

Similar Documents

Publication Publication Date Title
FR2132788B1 (cg-RX-API-DMAC7.html)
FR2121525B1 (cg-RX-API-DMAC7.html)
FR2121599A1 (cg-RX-API-DMAC7.html)
DK134529C (cg-RX-API-DMAC7.html)
FR2156255B1 (cg-RX-API-DMAC7.html)
FR2121697A1 (cg-RX-API-DMAC7.html)
FR2121796B1 (cg-RX-API-DMAC7.html)
FR2121333A5 (cg-RX-API-DMAC7.html)
DE2114916A1 (cg-RX-API-DMAC7.html)
CS150037B1 (cg-RX-API-DMAC7.html)
FR2109599A5 (cg-RX-API-DMAC7.html)
FI52341B (cg-RX-API-DMAC7.html)
FI52942C (cg-RX-API-DMAC7.html)
FI46677B (cg-RX-API-DMAC7.html)
CS148678B1 (cg-RX-API-DMAC7.html)
CS154158B1 (cg-RX-API-DMAC7.html)
CS149228B1 (cg-RX-API-DMAC7.html)
DE2120466A1 (cg-RX-API-DMAC7.html)
DE2119569A1 (cg-RX-API-DMAC7.html)
CS155407B1 (cg-RX-API-DMAC7.html)
CS154353B1 (cg-RX-API-DMAC7.html)
CH581993A5 (cg-RX-API-DMAC7.html)
BG18042A1 (cg-RX-API-DMAC7.html)
CH566022A5 (cg-RX-API-DMAC7.html)
DD100864A5 (cg-RX-API-DMAC7.html)